- Home
- BJ vs ARWR Comparison
BJ vs ARWR Comparison
Compare BJ & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BJ | ARWR |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 12.4B |
| IPO Year | 2018 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BJ | ARWR |
|---|---|---|
| Price | $105.62 | $58.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 15 |
| Target Price | $104.55 | ★ $107.36 |
| AVG Volume (30 Days) | ★ 1.9M | 1.7M |
| Earning Date | 11-20-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.50 | ★ 99.80 |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $21,457,274,000.00 | $16,142,321.00 |
| Revenue This Year | $11.72 | N/A |
| Revenue Next Year | $5.67 | N/A |
| P/E Ratio | $43.19 | ★ N/A |
| Revenue Growth | ★ 4.66 | N/A |
| 52 Week Low | $83.21 | $37.06 |
| 52 Week High | $106.61 | $95.49 |
Technical Indicators
Market Signals| Indicator | BJ | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 69.45 | 33.24 |
| Support Level | $89.76 | $54.96 |
| Resistance Level | $105.78 | $66.37 |
| Average True Range (ATR) | 2.73 | 2.28 |
| MACD | 0.60 | 0.53 |
| Stochastic Oscillator | 85.72 | 33.40 |
Price Performance
Historical ComparisonAbout BJ BJ's Wholesale Club Holdings Inc.
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 260 clubs and a growing domestic presence across 21 states. In fiscal 2025, the company generated over $21 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (72% of sales), general merchandise (11%), and gasoline (17%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.